• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Disposition of mitoxantrone in patients.

作者信息

Alberts D S, Peng Y M, Leigh S, Davis T P, Woodward D L

出版信息

Cancer Treat Rev. 1983 Dec;10 Suppl B:23-7. doi: 10.1016/0305-7372(83)90018-x.

DOI:10.1016/0305-7372(83)90018-x
PMID:6661732
Abstract
摘要

相似文献

1
Disposition of mitoxantrone in patients.米托蒽醌在患者体内的处置情况。
Cancer Treat Rev. 1983 Dec;10 Suppl B:23-7. doi: 10.1016/0305-7372(83)90018-x.
2
Mitoxantrone hydrochloride in lymphoma.盐酸米托蒽醌治疗淋巴瘤
Cancer Treat Rev. 1983 Dec;10 Suppl B:73-6. doi: 10.1016/0305-7372(83)90027-0.
3
Mitoxantrone in malignant lymphomas.米托蒽醌治疗恶性淋巴瘤
Cancer Treat Rev. 1983 Dec;10 Suppl B:69-72. doi: 10.1016/0305-7372(83)90026-9.
4
Southwest Oncology Group study of Mitoxantrone for treatment of patients with advanced squamous cell carcinoma of the head and neck.西南肿瘤协作组关于米托蒽醌治疗晚期头颈部鳞状细胞癌患者的研究。
Invest New Drugs. 1984;2(4):405-7. doi: 10.1007/BF00171594.
5
Combination chemotherapy with cyclophosphamide, mitoxantrone and 5-fluorouracil in patients with metastatic breast cancer.环磷酰胺、米托蒽醌和5-氟尿嘧啶联合化疗用于转移性乳腺癌患者。
Cancer Treat Rev. 1983 Dec;10 Suppl B:53-5. doi: 10.1016/0305-7372(83)90023-3.
6
Clinical safety and tolerance of mitoxantrone (Novantrone).米托蒽醌（诺维本）的临床安全性与耐受性。
Cancer Treat Rev. 1983 Dec;10 Suppl B:29-36. doi: 10.1016/0305-7372(83)90019-1.
7
Mitoxantrone as first line cytotoxic therapy in advanced breast cancer: preliminary results of a phase II study.米托蒽醌作为晚期乳腺癌一线细胞毒性治疗：一项II期研究的初步结果。
Cancer Treat Rev. 1983 Dec;10 Suppl B:47-52. doi: 10.1016/0305-7372(83)90022-1.
8
Phase II study of mitoxantrone in advanced squamous cell carcinoma of the head and neck. A Southeastern Cancer Study Group trial.米托蒽醌用于晚期头颈部鳞状细胞癌的II期研究。一项东南癌症研究组试验。
Invest New Drugs. 1985;3(3):311-3. doi: 10.1007/BF00179438.
9
[Local application of mitoxantrone in inoperable, stenosing esophageal carcinoma. Preliminary report].[米托蒽醌在不可切除的狭窄性食管癌中的局部应用。初步报告]
Onkologie. 1986 Feb;9(1):27-9. doi: 10.1159/000215955.
10
DDMP (2,4-diamino-5-(3',4'-dichlorophenyl)-methylpyrimidine).
Cancer Treat Rev. 1980 Jun;7(2):95-112. doi: 10.1016/s0305-7372(80)80019-3.

引用本文的文献

1
A physiologically based pharmacokinetic model of mitoxantrone in mice and scale-up to humans: a semi-mechanistic model incorporating DNA and protein binding.在小鼠和人体中米托蒽醌的基于生理的药代动力学模型：一种半机理模型，纳入 DNA 和蛋白质结合。
AAPS J. 2012 Jun;14(2):352-64. doi: 10.1208/s12248-012-9344-7. Epub 2012 Mar 27.
2
Mass balance studies, with a focus on anticancer drugs.以抗癌药物为重点的质量平衡研究。
Clin Pharmacokinet. 2006;45(1):33-58. doi: 10.2165/00003088-200645010-00003.
3
Pharmacology of mitoxantrone: mode of action and pharmacokinetics.
米托蒽醌的药理学：作用方式与药代动力学。
Invest New Drugs. 1985;3(2):101-7. doi: 10.1007/BF00174156.
4
The pharmacokinetics and metabolism of mitoxantrone in man.米托蒽醌在人体内的药代动力学和代谢
Invest New Drugs. 1985;3(2):109-16. doi: 10.1007/BF00174157.
5
Pharmacokinetics of mitoxantrone in humans following single-agent infusion or intra-arterial injection therapy or combined-agent infusion therapy.米托蒽醌在单药输注、动脉内注射治疗或联合用药输注治疗后的人体药代动力学。
Cancer Chemother Pharmacol. 1986;18(1):27-32. doi: 10.1007/BF00253059.
6
Comparative in vitro toxicity of mitoxantrone and adriamycin in human granulocyte-macrophage progenitor cells.米托蒽醌与阿霉素对人粒细胞-巨噬细胞祖细胞的体外毒性比较
Cancer Chemother Pharmacol. 1987;20(1):8-12. doi: 10.1007/BF00252951.
7
Effectiveness of mitoxantrone on the proliferation of cell cultures derived from malignant mesenchymal tumors of human origin.米托蒽醌对源自人类恶性间充质肿瘤的细胞培养物增殖的有效性。
J Cancer Res Clin Oncol. 1988;114(2):197-203. doi: 10.1007/BF00417837.
8
Pharmacokinetics and metabolism of mitoxantrone. A review.
Clin Pharmacokinet. 1990 May;18(5):365-80. doi: 10.2165/00003088-199018050-00003.
9
Clinical pharmacokinetics of mitoxantrone after intraperitoneal administration.米托蒽醌腹腔内给药后的临床药代动力学
Cancer Chemother Pharmacol. 1992;29(6):480-4. doi: 10.1007/BF00684852.
10
Pharmacokinetics of mitoxantrone in cancer patients treated by high-dose chemotherapy and autologous bone marrow transplantation.米托蒽醌在接受大剂量化疗和自体骨髓移植治疗的癌症患者中的药代动力学。
Br J Cancer. 1992 Mar;65(3):399-404. doi: 10.1038/bjc.1992.81.